Nitric oxide in preeclampsia: Lack of evidence for decreased production

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 76, Issue 1, 1998, Pages 65-70

  Di Iorio, Romolo ^a   Marinoni, Emanuela ^a   Emiliani, Serena ^a   Villaccio, Barbara ^a   Cosmi, Ermelando V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amniotic fluid; Nitric oxide; Placenta and fetal membranes; Preeclampsia

Indexed keywords

NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATERNAL PLASMA; NORMAL HUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; URINALYSIS;

EID: 0031962534     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(97)00159-0     Document Type: Article

References (26)

1. [1] Myatt L. Current topic: control of vascular resistance in the human placenta. Placenta 1992;3:1-13.
2. [2] Macara LM, Kingdom JCP, Kaufmann P. Control of fetoplacental circulation. Fetal Maternal Med Rev 1993;5:167-79.
3. [3] Redman CWG. Current topic: preeclampsia and the placenta. Placenta 1991;12:301-8.
4. [4] Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
5. [5] Roberts JM, Taylor RN, Goldfien A. Clinical and biological evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991;4:700-8.
6. [6] Hull AD, White CR, Pearce WJ. Endothelium-derived relaxing factor and cyclic GMP-dependent vasorelaxation in human chorionic plate arteries. Placenta 1994;15:363-75.
7. [7] Gude NM. Endothelium-derived relaxing factor [nitric oxide] and the placenta. In: Rice GE, Breenecke SP, editors. Molecular aspects of placenta and fetal membranes autacoids. CRC, Boca Raton, FL, 1993:263-76.
8. [8] Buttery LDK, McCarthy A, Springall DR et al. Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994;15:257-65.
9. [9] Cameron IT, van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relation between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993;12:85-92.
10. [10] Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993;169:1316-20.
11. [11] Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995;173:714-8.
12. [12] Rutherford RAD, McCarthy A, Sullivan MHF, Elder MG, Polak JM, Wharton J. Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies. Br J Pharmacol 1995;116:3099-109.
13. [13] Seligman SP, Buyon JP, Clancy RM, Young K, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171:944-8.
14. [14] Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996;174:1008-13.
15. [15] Curtis NE, Gude NM, King RG et al. Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypertens Pregnancy 1995;14:339-49.
16. [16] Brown MA, Tibben E, Zammit VC, Carlo GM, Carlton MA. Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Pregnancy 1995;14:319-26.
17. [17] Myatt L, Brockman DE, Langdon G, Pollock JS. Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 1993;14:373-83.
18. [18] Ramsay B, Sooranna SR, Johnson MR. Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy. Obstet Gynecol 1996;87:249-53.
19. [19] Marinoni E, Picca A, Scucchi L, Cosmi EV, Di Iorio R. Immunohistochemical localization of endothelin-1 in placenta and fetal membranes in term and preterm human pregnancy. Am J Reprod Immunol 1995;34:213-8.
20. [20] Ghabour MS, Eis ALW, Brockman DE, Pollock JS, Myatt L. Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia. Am J Obstet Gynecol 1995;173:687-94.
21. [21] Di Iorio R, Marinoni E, Anceschi MM, Emiliani S, Letizia C, Cosmi EV Amniotic fluid endothelin-1 levels are increased in pregnancy-induced hypertension and intrauterine growth retardation. Am J Reprod Immunol 1996;36:260-3.
22. [22] Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
23. [23] Zhang ZG, Chopp M, Zaloga C, Pollock JS, Forstermann U. Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 1993;24:2016-22.
24. [24] Roe CM, Leitch IM, Boura LA, Smith R. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro. J Clin Endocrinol Metab 1996;81:763-9.
25. [25] Holcberg G, Kossenjans W, Miodovnik M, Myatt L. The interaction of nitric oxide and superoxide in the human fetal-placental vasculature. Am J Obstet Gynecol 1995;173:528-33.
26. [26] Clifton VL, Read MA, Leitch IM et al. Corticotropin-releasing hormone-induced vasodilation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-mono-phosphate-mediated pathway. J Clin Endocrinol Metab 1995;80:2888-93.